Johnson & Johnson (JNJ)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 11 |
Ownership rank: | 21 |
% of all portfolios: | 0.221% |
Hold Price * : | $162.05 |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
0 |
$0 |
Sells |
1 |
$930,113 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
≡ |
Charles Bobrinskoy - Ariel Focus Fund |
2.86 |
|
11,936 |
1,934,000 |
≡ |
Torray Funds |
2.52 |
Add 27.36% |
111,264 |
18,031,000 |
≡ |
Tweedy Browne Co. - Tweedy Browne Value Fund |
2.39 |
|
63,514 |
10,293,000 |
≡ |
Yacktman Asset Management |
2.35 |
Reduce 6.20% |
1,413,400 |
229,056,000 |
≡ |
Jensen Investment Management |
2.29 |
Reduce 11.07% |
1,688,595 |
273,654,000 |
≡ |
Robert Olstein - Olstein Capital Management |
1.68 |
|
61,000 |
9,886,000 |
≡ |
Mairs & Power Growth Fund |
1.32 |
Reduce 9.21% |
465,975 |
75,516,000 |
≡ |
Prem Watsa - Fairfax Financial Holdings |
1.08 |
|
73,400 |
11,891,000 |
≡ |
Thomas Gayner - Markel Group |
0.89 |
|
610,800 |
98,986,000 |
≡ |
David Katz - Matrix Asset Advisors |
0.06 |
Add 0.90% |
3,375 |
547,000 |
≡ |
Lindsell Train |
0.02 |
|
6,065 |
983,000 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock